RT wrote that the American pharmaceutical giant turned a blind eye to the pandemic. The pandemic caused 3.2 million deaths, but it did not help poor countries at all.
According to him New York Times, Pfizer’s revenue in the first quarter of 2021 was 3.5 billion U.S. dollars. The company did not specify exactly how much profit it made from the covida-19 vaccine, but reiterated that the vaccine’s profit was about 20%, which means that Comirnaty’s vaccine revenue is approximately US$900 million (before tax).
What’s interesting about the company’s success is that its vaccine is one of two vaccines used only on a profit-based basis. RT wrote that Pfizer did not want to follow in the footsteps of Western competitors Johnson & Johnson and AstraZeneca, and immediately decided to make money from its vaccines.
Unlike its rival Moderna, which uses similar technology, Pfizer is a well-known company with revenues of $9.6 billion by 2020 and is not affected by the production of the covid-19 vaccine during this period. On the other hand, Hyundai has no other products on the market, so profit from vaccines is vital to the company’s survival-Pfizer is definitely not the case.
The company is also not very transparent about contracts with various countries. For example, the United States pays Pfizer US$19.50 per dose, while Israel, according to multiple media reports, has agreed to pay Pfizer US$30 per dose. Pfizer has repeatedly stated that this differently priced game is morally reasonable because it has never been part of the US Warp Speed program and therefore has the right to set its own price.
But that is not the case. Pfizer’s partner BioNTech is actually the company that develops the Comirnaty vaccine. It has received US$455 million in support from the German government and US$6 billion in support from the United States and the European Union. Not only that, Pfizer’s vaccine is based on mRNA technology, which has been patented by the National Institutes of Health and funded by US taxpayers.
In short, Pfizer used a partnership with an unknown German biotechnology company at the time, which received support from the German government to develop its vaccine based on technology funded by US taxpayers, and then signed agreements with rich countries Sales contracts to ensure billions of dollars in revenue.
But when people think that this is a public health crisis, millions of people die in a short period of time, the exact extent of this huge corruption becomes clear.
Political commentator Bradley Blankenship wrote that intellectual property (IP) laws are clearly an obstacle to widespread and equal distribution of doses worldwide.
He pointed out that even US President Joe Biden said in 2020 that he will suspend intellectual property protection in order to provide vaccines to people around the world.
Blankenship does not believe that IP is the only problem, but for many states, proving the overhead and logistics of Pfizer vaccine transportation is challenging. On the other hand, Pfizer is one of the most important vaccines in the Western market, and cheap vaccines are not credible.
Oxford University announced on April 15 Learn This indicates that the risk of portal vein thrombosis (blood clot in the liver) using mRNA vaccines Moderna and Pfizer is 30 times higher than the risk of using AstraZeneca. Therefore, although people’s concerns about blood clotting have caused controversy, public suspicion, and even the abolition of AstraZeneca and Johnson & Johnson vaccines in some countries, the media has hardly mentioned the connection between mRNA vaccines and blood clot formation. Counterclockwise.
The CEO of Pfizer has vowed to ensure that poorer countries “get the same vaccination opportunities as the rest of the world.” But the World Health Organization (WHO) said in mid-April that rich countries provided more than 87% of the 700 million doses of coronavirus vaccine distributed worldwide, while poor countries only provided 0.2%. In rich countries, about a quarter of people are vaccinated, while in poor countries, it is one in five.
The company said on Tuesday that it has provided 430 million doses to 91 countries or regions. Pfizer spokesperson Sharon Castillo did not disclose how much of these doses went to poor countries where Pfizer could not profit from vaccine sales.
WHO’s data clearly shows that Pfizer provides very little assistance to the world’s poorest countries. The company is committed to providing Covax with up to 40 million doses of vaccines. The organization aims to provide vaccines to low- and middle-income countries. Pfizer and its partner BioNTech plan to produce less than the 2.5 billion doses of vaccines this year. 2%.